TY - JOUR
T1 - Invasive mucinous cystic neoplasms of the pancreas
AU - Baker, Michael L.
AU - Seeley, E. Scott
AU - Pai, Reetesh
AU - Suriawinata, Arief A.
AU - Mino-Kenudson, Mari
AU - Zamboni, Giuseppe
AU - Klöppel, Günter
AU - Longnecker, Daniel S.
PY - 2012/12
Y1 - 2012/12
N2 - Mucinous cystic neoplasms (MCN) and intraductal papillary mucinous neoplasms (IPMN) of the pancreas both appear to have been included and intermixed in some early reports of pancreatic cystic neoplasms. Recognition of their distinguishing features evolved during the last decade of the twentieth century. One legacy of the early period is the statement that mucinous cystic neoplasms sometimes progress to invasive colloid carcinoma. It is now recognized that colloid carcinomas characteristically arise from IPMN. We set out to see if we could find MCN that invaded as colloid carcinomas and found no examples in MCN collected in two academic medical centers. We then sought to expand the number of MCN by evaluating series from additional centers. This yielded no examples of colloid carcinomas associated with 291 MCN, however one MCN exhibited a minor component with colloid (non-cystic mucinous) growth pattern within the fibrous wall of the neoplasm. The expression of CDX2, a marker of intestinal differentiation that is found in colloid carcinomas was examined by immunostaining in the original MCN series and in the MCN with the intratumoral colloid growth pattern. Focal expression of CDX2 was found in 22 of 43 MCN including the MCN that exhibited the intratumoral colloid growth pattern. Overall, the data suggest that MCN rarely, if ever, invade as colloid carcinoma but the expression of CDX2 by some MCN and the observation of intratumoral colloid growth pattern in one MCN seems to leave open the possibility that MCN might rarely invade as colloid carcinoma.The majority of malignant MCN invade with a tubular (ductal) pattern, and rarely the invasive component was anaplastic.
AB - Mucinous cystic neoplasms (MCN) and intraductal papillary mucinous neoplasms (IPMN) of the pancreas both appear to have been included and intermixed in some early reports of pancreatic cystic neoplasms. Recognition of their distinguishing features evolved during the last decade of the twentieth century. One legacy of the early period is the statement that mucinous cystic neoplasms sometimes progress to invasive colloid carcinoma. It is now recognized that colloid carcinomas characteristically arise from IPMN. We set out to see if we could find MCN that invaded as colloid carcinomas and found no examples in MCN collected in two academic medical centers. We then sought to expand the number of MCN by evaluating series from additional centers. This yielded no examples of colloid carcinomas associated with 291 MCN, however one MCN exhibited a minor component with colloid (non-cystic mucinous) growth pattern within the fibrous wall of the neoplasm. The expression of CDX2, a marker of intestinal differentiation that is found in colloid carcinomas was examined by immunostaining in the original MCN series and in the MCN with the intratumoral colloid growth pattern. Focal expression of CDX2 was found in 22 of 43 MCN including the MCN that exhibited the intratumoral colloid growth pattern. Overall, the data suggest that MCN rarely, if ever, invade as colloid carcinoma but the expression of CDX2 by some MCN and the observation of intratumoral colloid growth pattern in one MCN seems to leave open the possibility that MCN might rarely invade as colloid carcinoma.The majority of malignant MCN invade with a tubular (ductal) pattern, and rarely the invasive component was anaplastic.
KW - CDX2
KW - Colloid carcinoma
KW - Intraductal papillary mucinous neoplasm
KW - MUC2
KW - Mucinous cystadenocarcinoma
KW - Mucinous cystadenoma
KW - Mucinous cystic neoplasm
KW - Pancreas
UR - http://www.scopus.com/inward/record.url?scp=84872411513&partnerID=8YFLogxK
U2 - 10.1016/j.yexmp.2012.07.005
DO - 10.1016/j.yexmp.2012.07.005
M3 - Article
C2 - 22902940
AN - SCOPUS:84872411513
SN - 0014-4800
VL - 93
SP - 345
EP - 349
JO - Experimental and Molecular Pathology
JF - Experimental and Molecular Pathology
IS - 3
ER -